Why Nektar Therapeutics Stock Zoomed More Than 15% Higher Today
One of the company's pipeline drugs is showing significant promise. Clinical-stage biotech Nektar Therapeutics (NKTR 15.06%) had some encouraging news to report from the lab…
Rakovina Therapeutics Increases Private Placement Offering to $3.0 Million
This section is Partnership Content suppliedThe content in this section is supplied by GlobeNewswire for the purposes of distributing press releases on behalf of its…
Io Therapeutics, Inc., announces presentation of data on its RAR gamma agonist compound IRX5010 demonstrating inhibition of tumor infiltrating myeloid derived suppressor cells, promotion of tumor infiltrating T-cells, and effective tumor growth inhibition in murine models of breast, colorectal, and prostate cancers
This section is Partnership Content suppliedThe content in this section is supplied by GlobeNewswire for the purposes of distributing press releases on behalf of its…